Skip to main content
Premium Trial:

Request an Annual Quote

DermTech: DermTech PLAplus

DermTech has launched its PLAplus test, which adds telomerase reverse transcriptase promoter DNA driver mutation analyses to the firm's current RNA gene expression based Pigmented Lesion Assay (PLA) for early melanoma detection. The firm said the add-on improves the combined tests' sensitivity from 91 percent to 97 percent. 

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.